Bart Hens

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Venues

Molecular pharmaceutics

Pharmaceutics

Proceedings of the National Academy of Sciences of the United States of America

PloS one

University Of Michigan

KU Leuven (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Of Michigan Jan 01 2017

United States

Visiting Research Investigator :: Pharmaceutical Sciences

Education History

KU Leuven Jan 01 2018

Belgium

PHD :: Department of Pharmaceutical & Pharmacological Sciences

Publications

Niloufar Salehi, Jozef Al-Gousous, Bart Hens, Gordon L Amidon, Robert M Ziff, Gregory E Amidon
Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation. Molecular pharmaceutics 21 (5) (2024)
Niloufar Salehi, Jozef Al-Gousous, Bart Hens, Gordon L Amidon, Robert M Ziff, Gregory E Amidon
Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation. Molecular pharmaceutics (2024)
Bart Hens
Voices in Molecular Pharmaceutics: Meet Dr. Bart Hens, A Sociable Scientist Focusing on Multidisciplinary Connections to Unravel the Gaps of Oral Drug Behavior in the Human Gastrointestinal Tract. Molecular pharmaceutics (2023)
Inese Sarcevica, Bart Hens, Irena Tomaszewska, Mark McAllister
Digitalizing the TIM-1 Model using Computational Approaches-Part One: TIM-1 Data Explorer. Molecular pharmaceutics (2023)
Joseph Piscitelli, Bart Hens, Irena Tomaszewska, Lance Wollenberg, Kevin Litwiler, Mark McAllister, Micaela B Reddy
Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An In Vivo - In Vitro - In Silico Approach. Molecular pharmaceutics (2023)
Bart Hens, Inese Sarcevica, Irena Tomaszewska, Mark McAllister
Digitalizing the TIM-1 Model Using Computational Approaches─Part Two: Digital TIM-1 Model in GastroPlus. Molecular pharmaceutics (2023)
Bart Hens, Isabel González-Álvarez, Marival Bermejo
Exploring the Predictive Power of the In Situ Perfusion Technique towards Drug Absorption: Theory, Practice, and Applications. Molecular pharmaceutics 19 (3) (2022)
Isabel González-Álvarez, Marival Bermejo, Yasuhiro Tsume, Alejandro Ruiz-Picazo, Marta González-Álvarez, Bart Hens, Alfredo Garcia-Arieta, Greg E Amidon, Gordon L Amidon
An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products. Pharmaceutics 13 (4) (2021)
Suzanne J F Kaptein, Sofie Jacobs, Lana Langendries, Laura Seldeslachts, Sebastiaan Ter Horst, Laurens Liesenborghs, Bart Hens, Valentijn Vergote, Elisabeth Heylen, Karine Barthelemy, Elke Maas, Carolien De Keyzer, Lindsey Bervoets, Jasper Rymenants, Tina Van Buyten, Xin Zhang, Rana Abdelnabi, Juanita Pang, Rachel Williams, Hendrik-Jan Thibaut, Kai Dallmeier, Robbert Boudewijns, Jens Wouters, Patrick Augustijns, Nick Verougstraete, Christopher J Cawthorne, Judith Breuer, Caroline Solas, Birgit Weynand, Pieter Annaert, Isabel Spriet, Greetje Vande Velde, Johan Neyts, Joana Rocha-Pereira, Leen Delang
Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. Proceedings of the National Academy of Sciences of the United States of America 117 (43) (2020)
Bart Hens, Marival Bermejo, Patrick Augustijns, Rodrigo Cristofoletti, Gregory E Amidon, Gordon L Amidon
Erratum: Hens, B.; et al. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola® on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b). Pharmaceutics, 2020, 12, 566. Pharmaceutics 12 (12) (2020)
Sandra Suarez-Sharp, Anders Lindahl, Tycho Heimbach, Amin Rostami-Hodjegan, Michael B Bolger, Siladitya Ray Chaudhuri, Bart Hens
Translational Modeling Strategies for Orally Administered Drug Products: Academic, Industrial and Regulatory Perspectives. Pharmaceutical research 37 (6) (2020)
Marival Bermejo, Bart Hens, Joseph Dickens, Deanna M Mudie, Paulo Paixão, Yasuhiro Tsume, Kerby Shedden, Gordon L Amidon
A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP. Pharmaceutics 12 (1) (2020)
Khaled Heissam, Nichola Abrehart, Caroline L Hoad, Jeff Wright, Alex Menys, Kathryn Murray, Paul M Glover, Geoffrey Hebbard, Penny A Gowland, Jason Baker, William L Hasler, Robin C Spiller, Maura Corsetti, James G Brasseur, Bart Hens, Kerby Shedden, Joseph Dickens, Deanna M Mudie, Greg E Amidon, Gordon L Amidon, Luca Marciani
Measurement of fasted state gastric antral motility before and after a standard bioavailability and bioequivalence 240 mL drink of water: Validation of MRI method against concomitant perfused manometry in healthy participants. PloS one 15 (11) (2020)
Jozef Al-Gousous, Kathy X Sun, Daniel P McNamara, Bart Hens, Niloufar Salehi, Peter Langguth, Marival Bermejo, Gregory E Amidon, Gordon L Amidon
Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate-CO2 Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical Significance. Molecular pharmaceutics 15 (11) (2018)
Marival Bermejo, Paulo Paixão, Bart Hens, Yasuhiro Tsume, Mark J Koenigsknecht, Jason R Baker, William L Hasler, Robert Lionberger, Jianghong Fan, Joseph Dickens, Kerby Shedden, Bo Wen, Jeffrey Wysocki, Raimar Löbenberg, Allen Lee, Ann Frances, Gregory E Amidon, Alex Yu, Niloufar Salehi, Arjang Talattof, Gail Benninghoff, Duxin Sun, Gislaine Kuminek, Katie L Cavanagh, Naír Rodríguez-Hornedo, Gordon L Amidon
Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions. Molecular pharmaceutics 15 (12) (2018)
Paulo Paixão, Marival Bermejo, Bart Hens, Yasuhiro Tsume, Joseph Dickens, Kerby Shedden, Niloufar Salehi, Mark J Koenigsknecht, Jason R Baker, William L Hasler, Robert Lionberger, Jianghong Fan, Jeffrey Wysocki, Bo Wen, Allen Lee, Ann Frances, Gregory E Amidon, Alex Yu, Gail Benninghoff, Raimar Löbenberg, Arjang Talattof, Duxin Sun, Gordon L Amidon
Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 2: Fed State. Molecular pharmaceutics 15 (12) (2018)
Bart Hens, Luc Hens
Persistent Threats by Persistent Pollutants: Chemical Nature, Concerns and Future Policy Regarding PCBs-What Are We Heading For? Toxics 6 (1) (2017)
Bart Hens, Shriram M Pathak, Amitava Mitra, Nikunjkumar Patel, Bo Liu, Sanjaykumar Patel, Masoud Jamei, Joachim Brouwers, Patrick Augustijns, David B Turner
In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole. Molecular pharmaceutics 14 (12) (2017)
Bart Hens, Yasuhiro Tsume, Marival Bermejo, Paulo Paixao, Mark J Koenigsknecht, Jason R Baker, William L Hasler, Robert Lionberger, Jianghong Fan, Joseph Dickens, Kerby Shedden, Bo Wen, Jeffrey Wysocki, Raimar Loebenberg, Allen Lee, Ann Frances, Greg Amidon, Alex Yu, Gail Benninghoff, Niloufar Salehi, Arjang Talattof, Duxin Sun, Gordon L Amidon
Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs. Molecular pharmaceutics 14 (12) (2017)

Bart Hens.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bart Hens